---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-029340"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:46:06.756215+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.04
calibrated_materiality_score: 0.04
confidence: "high"
source: SEC EDGAR
---

# Aquestive Therapeutics reports 2024 annual meeting voting results

## Summary
- Elected Santo J. Costa, Julie Krop, and Marco Taglietti as Class III directors with 24.9M, 21.6M, and 24.9M votes for.
- Non-binding advisory vote on executive compensation approved: 23.6M for, 1.6M against.
- Advisory vote frequency set at one year (24.6M for).
- Ratified KPMG as independent auditor for FY 2024: 50.7M for, 0.9M against.

## SEC filing metadata
- accession: 0001628280-24-029340
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.04
- calibrated_materiality_score: 0.04
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828024029340/0001628280-24-029340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828024029340/aqst-20240620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-029340
- JSON: https://secwatch.observer/filing/0001628280-24-029340.json
- Plain text: https://secwatch.observer/filing/0001628280-24-029340.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.